🇺🇸 FDA
Patent

US 11246947

Recombinant AAV-crumbs homologue composition and methods for treating LCA-8 and progressive RP

granted A61KA61K35/76A61K48/005

Quick answer

US patent 11246947 (Recombinant AAV-crumbs homologue composition and methods for treating LCA-8 and progressive RP) held by Academisch Ziekenhuis Leiden h.o.d.n. Leids Universitair Medisch Centrum expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Academisch Ziekenhuis Leiden h.o.d.n. Leids Universitair Medisch Centrum
Grant date
Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K35/76, A61K48/005, A61K48/0075, A61P